Floatz logo

Therapeutic Asset Ratings

6,308 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Osimertinib
Small Cell Lung Carcinoma
Misty ShieldsP1/2CC (47)
Oxodotreotide
Ependymoma
Fundación de investigación HMP1/2CC (47)
Oxodotreotide
Estrogen-Receptor Positive Breast Cancer
RayzeBio, Inc.P1/2CC (47)
Oxodotreotide
Meningioma
Fundación de investigación HMP1/2CC (47)
Oxodotreotide
Pheochromocytoma
Fundación de investigación HMP1/2CC (47)
p134 cell
IDH-Wildtype Glioblastoma
Tasly Pharmaceutical Group Co., LtdP1/2CC (47)
Palacaparib
Squamous Cell Lung Carcinoma
AstraZenecaP1/2CC (47)
Pasifolate Exatecan
Ovarian Serous Adenocarcinoma
Elucida OncologyP1/2CC (47)
Patritumab Deruxtecan
Esophageal Cancer
Merck Sharp & Dohme LLCP1/2CC (47)
Patritumab Deruxtecan
Gastroesophageal Junction Adenocarcinoma
Merck Sharp & Dohme LLCP1/2CC (47)
Paxalisib
Malignant Glioma
Institute of Cancer Research, United KingdomP1/2CC (47)
pds01adc
Vaginal Cancer
National Cancer Institute (NCI)P1/2CC (47)
pds01adc
Vulva Cancer
National Cancer Institute (NCI)P1/2CC (47)
PE0105
Metastatic Neoplasm
Shanghai HyaMab Biotech Co.,Ltd.P1/2CC (47)
Pegargiminase
Diffuse Midline Glioma, H3 K27M-Mutant
Sabine Mueller, MD, PhDP1/2CC (47)
Pegcetacoplan
Malignant Pancreatic Neoplasm
Roswell Park Cancer InstituteP1/2CC (47)
Pembrolizumab
Biliary Tract Neoplasm
Eli Lilly and CompanyP1/2CC (47)
Pembrolizumab
Leukemia
Essen BiotechP1/2CC (47)
Pembrolizumab
Meningioma
Essen BiotechP1/2CC (47)
Penpulimab
Head And Neck Squamous Cell Carcinoma
AkesoP1/2CC (47)
Perflubutane
Pancreatic Ductal Adenocarcinoma
Flemming ForsbergP1/2CC (47)
Pertzye
Exocrine Pancreatic Carcinoma
Memorial Sloan Kettering Cancer CenterP1/2CC (47)
Petosemtamab
Gastroesophageal Junction Adenocarcinoma
Merus B.V.P1/2CC (47)
Pevonedistat
Myeloid Neoplasm
M.D. Anderson Cancer CenterP1/2CC (47)
pf-08634404
Renal Cell Carcinoma
PfizerP1/2CC (47)
Showing 2526 to 2550 of 6,308 assets
PreviousPage 102 of 253Next